ArticleFrontiers in oncology2021

Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients.

Hélène Carinato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.